131030 — Optus Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual cashflow statement for Optus Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	14,405	9,892	5,012	10,760	10,308
Depreciation
Amortisation
Non-Cash Items	2,100	1,759	1,407	-779	283
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-1,644	-7,002	-7,837	-1,781	-5,663
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	17,446	7,071	2,045	12,438	8,905
Capital Expenditures	-5,842	-10,628	-6,001	-3,329	-25,740
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-567	-4,595	-10,265	400	28,030
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-6,410	-15,223	-16,266	-2,929	2,290
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-3,761	-1,715	-7,927	-2,105	-2,139
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	7,266	-9,867	-22,146	7,402	9,095